Differential CpG Island Methylation in Down Syndrome
唐氏综合症中 CpG 岛甲基化的差异
基本信息
- 批准号:7331691
- 负责人:
- 金额:$ 3.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAneuploidyBiological AssayCerebellumCerebrumChromosomesChromosomes, Human, Pair 21CommunitiesComplexComputer softwareCongenital Heart DefectsCpG IslandsCpG dinucleotideCytosineDNADNA Modification ProcessDNA copy numberDataData AnalysesDevelopmentDiseaseDown SyndromeEpigenetic ProcessFinancial compensationFreezingGene DosageGene ExpressionGenetic MaterialsGenetic TranscriptionHeartHereditary DiseaseHumanImageryIndividualInternetIslandKnowledgeLaboratory StudyLeukocytesLive BirthMental RetardationMethodsMethylationModelingModificationMolecularNumbersPathologyPathology, OtherPhenotypePlayPolymerase Chain ReactionProteinsProteomicsRNARangeRateReportingResearchResourcesRoleSamplingSiteSourceSurveysTechnologyTestingTimeTissuesTranscriptTrisomyVariantWorkbasebisulfitedeoxyhypusine synthasedosagefetalhuman fetus tissueinsightperipheral bloodresearch studyrestriction enzymetool
项目摘要
DESCRIPTION (provided by applicant): Down syndrome is caused by trisomy 21 (TS21) (an extra copy of chromosome 21). TS21 leads to a broad spectrum of phenotypes including mental retardation and various heart defects. TS21 is the primary model for understanding aneuploidies or aberrant chromosomal numbers and the numerous genetic disorders they cause. The most widely accepted hypothesis concerning the pathology of Down syndrome is known as the gene dosage hypothesis. Chromosome 21 RNA transcripts are increased in individuals with Down syndrome as compared to the RNA transcripts in normal individuals. Many transcripts are expressed at much higher or lower levels than the theoretical 1.5 fold increase, which indicates that factors other than the three copies of chromosome 21 are involved in regulating the RNA transcript levels. Epigenetic modifications are a major source of transcription control. The broad, long-term objective of the proposed research is to understand any epigenetic changes occurring in TS21 as a model for other disorders caused by increases in chromosomal copy number. Epigenetic changes will be examined by determining the methylation status of CpG islands using bisulfite sequencing. Advances in bisulfite sequencing technology will allow large amounts of data to be generated, providing the opportunity for comprehensive data on methylation changes. Data analysis and visualization tools will be developed to provide an accurate and complete understanding of the data. Abnormal amounts of genetic material are a primary cause of genetic disorders. In Down syndrome, an extra copy of chromosome 21 leads to an increase in the level of RNA generated from chromosome 21 and ultimately the features of the disorder. Understanding modification of the DNA (which plays a significant role in how much RNA is generated) is an important step in understanding these types of genetic disorders. The proposed research will examine DNA modifications and their relationship to RNA levels in Down syndrome. The results of this research will act as a model for other disorders caused by abnormal amounts of genetic material.
描述(由申请人提供):唐氏综合症由21三体(TS21)(21号染色体的额外副本)引起。TS21导致广泛的表型,包括智力迟钝和各种心脏缺陷。TS21是了解非整倍体或异常染色体数目及其引起的众多遗传疾病的主要模型。关于唐氏综合症的病理,最被广泛接受的假说是基因剂量假说。与正常个体的RNA转录相比,唐氏综合症患者的21号染色体RNA转录增加。许多转录本的表达水平远高于或低于理论的1.5倍,这表明除了21号染色体的三个拷贝外,还有其他因素参与调节RNA转录本水平。表观遗传修饰是转录控制的主要来源。拟议研究的广泛和长期目标是了解TS21中发生的任何表观遗传变化,作为染色体拷贝数增加引起的其他疾病的模型。表观遗传变化将通过使用亚硫酸盐测序确定CpG岛的甲基化状态来检查。亚硫酸酯测序技术的进步将产生大量数据,为甲基化变化的全面数据提供机会。将开发数据分析和可视化工具,以提供对数据的准确和完整的理解。异常数量的遗传物质是遗传疾病的主要原因。在唐氏综合症中,21号染色体的额外拷贝导致21号染色体产生的RNA水平增加,并最终导致该疾病的特征。了解DNA的修饰(它在RNA的产生中起着重要的作用)是了解这些类型的遗传疾病的重要一步。这项拟议的研究将检查唐氏综合症患者的DNA修饰及其与RNA水平的关系。这项研究的结果将作为由异常数量的遗传物质引起的其他疾病的模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NATHANIEL D MILLER其他文献
NATHANIEL D MILLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NATHANIEL D MILLER', 18)}}的其他基金
Differential CpG Island Methylation in Down Syndrome
唐氏综合症中 CpG 岛甲基化的差异
- 批准号:
7647898 - 财政年份:2007
- 资助金额:
$ 3.71万 - 项目类别:
Differential CpG Island Methylation in Down Syndrome
唐氏综合症中 CpG 岛甲基化的差异
- 批准号:
7487030 - 财政年份:2007
- 资助金额:
$ 3.71万 - 项目类别:
相似海外基金
Elucidating the effects of extra chromosome elimination in mosaic aneuploidy syndromes: Pallister-Killian syndrome as a model
阐明额外染色体消除对嵌合非整倍体综合征的影响:以 Pallister-Killian 综合征为模型
- 批准号:
10887038 - 财政年份:2023
- 资助金额:
$ 3.71万 - 项目类别:
Characterization of aneuploidy, cell fate and mosaicism in early development
早期发育中非整倍性、细胞命运和嵌合体的表征
- 批准号:
10877239 - 财政年份:2023
- 资助金额:
$ 3.71万 - 项目类别:
The impact of aneuploidy on early human development
非整倍体对人类早期发育的影响
- 批准号:
MR/X007979/1 - 财政年份:2023
- 资助金额:
$ 3.71万 - 项目类别:
Research Grant
Understanding how aneuploidy disrupts quiescence in the model eukaryote Saccharomyces cerevisiae
了解非整倍体如何破坏模型真核生物酿酒酵母的静止状态
- 批准号:
10735074 - 财政年份:2023
- 资助金额:
$ 3.71万 - 项目类别:
Preventing Age-Associated Oocyte Aneuploidy: Mechanisms Behind the Drosophila melanogaster Centromere Effect
预防与年龄相关的卵母细胞非整倍性:果蝇着丝粒效应背后的机制
- 批准号:
10538074 - 财政年份:2022
- 资助金额:
$ 3.71万 - 项目类别:
Functional evaluation of kinesin gene variants associated with female subfertility and egg aneuploidy.
与女性生育力低下和卵子非整倍性相关的驱动蛋白基因变异的功能评估。
- 批准号:
10537275 - 财政年份:2022
- 资助金额:
$ 3.71万 - 项目类别:
Using CRISPR screening to uncover aneuploidy-specific genetic dependencies
使用 CRISPR 筛选揭示非整倍体特异性遗传依赖性
- 批准号:
10661533 - 财政年份:2022
- 资助金额:
$ 3.71万 - 项目类别:
Comparative Analysis of Aneuploidy and Cellular Fragmentation Dynamics in Mammalian Embryos
哺乳动物胚胎非整倍性和细胞破碎动力学的比较分析
- 批准号:
10366610 - 财政年份:2022
- 资助金额:
$ 3.71万 - 项目类别:
FASEB SRC: The Consequences of Aneuploidy: Honoring the Contributions of Angelika Amon
FASEB SRC:非整倍体的后果:纪念 Angelika Amon 的贡献
- 批准号:
10467260 - 财政年份:2022
- 资助金额:
$ 3.71万 - 项目类别: